Keyphrases
Adenovirus
100%
Diabetic Retinopathy
100%
CD59
100%
AAV2
100%
Membrane Attack Complex
83%
Diabetic Eye
66%
Virus
33%
Retina
33%
Retinal Blood Vessels
33%
Advanced Stage
16%
Attenuation
16%
Gene Therapy
16%
Vascular Cells
16%
Myopic Choroidal Neovascularization (mCNV)
16%
Adeno-associated Viral Vector
16%
Therapy Approaches
16%
Membrane-associated
16%
Streptozotocin-induced Diabetes
16%
Potential Therapy
16%
Retinal Vascular Network
16%
Negative Control
16%
CD55
16%
Viral Gene Therapy
16%
Complement Regulators
16%
Working Adults
16%
Retinal Ganglion Cell Apoptosis
16%
Therapy Interventions
16%
Nonperfusion
16%
Neural Cell Damage
16%
Visual Dysfunction
16%
Neuroscience
Adeno-Associated Virus
100%
Diabetic Retinopathy
100%
Complement Membrane Attack Complex
100%
CD59
100%
Retinal Blood Vessel
40%
Cell Damage
20%
Choroidal Neovascularization
20%
Adeno Associated Virus Vector
20%
Nervous System Cell
20%
Streptozotocin
20%
Virus Gene
20%
Decay Accelerating Factor
20%
Retinal Ganglion Cell
20%
Visual Dysfunction
20%
Medicine and Dentistry
Diabetic Retinopathy
100%
Complement Membrane Attack Complex
100%
Adeno-Associated Virus
100%
Retinal Blood Vessel
40%
Disease
20%
Programmed Cell Death
20%
Gene Therapy
20%
Cell Damage
20%
Choroidal Neovascularization
20%
Streptozotocin-Induced Diabetes Mellitus
20%
Adeno Associated Virus Vector
20%
Ganglion
20%
Decay Accelerating Factor
20%
Nervous System Cell
20%
Visual Dysfunction
20%
Viral Gene Therapy
20%
Complement Regulator
20%
Biochemistry, Genetics and Molecular Biology
Complement Membrane Attack Complex
100%
Adeno Associated Virus
100%
CD59
100%
Gene Therapy
40%
Animal Model
20%
Cell Damage
20%
Perfusion
20%
Streptozotocin
20%
Decay-Accelerating Factor
20%
Adeno Associated Virus Vector
20%
Retinal Ganglion Cell
20%
Subretinal Neovascularization
20%
Immunology and Microbiology
Adeno Associated Virus
100%
Complement Membrane Attack Complex
100%
CD59
100%
Blood Vessels
40%
Ganglion
20%
Cell Damage
20%
Perfusion
20%
Subretinal Neovascularization
20%
Virus Gene
20%
Decay-Accelerating Factor
20%
Complement Regulator
20%
Adeno Associated Virus Vector
20%